Patent · US Active

Inhibitors of bacterial growth

US10695322B2 · kind B2 · utility

0Cited by
39References
15Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJan 26, 2017
Grant dateJun 30, 2020
Priority date
Expiry dateJan 26, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D499/897
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

New antimicrobials targeting L,D-transpeptidases, non-classical cysteine peptidases, have been developed and their unique chemical structures identified. Carbapenems and penems of the present invention are unique among β-lactams as they acylate and inhibit L,D-transpeptidases, which likely results in their superior antimicrobial potency. These new antimicrobial agents can be used alone, or in combination with other classic antimicrobial agents that target D,D transpeptidases, when treating bacterial infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.